Fogarty International Center; Notice of Meeting, 18567 [2011-7918]
Download as PDF
Federal Register / Vol. 76, No. 64 / Monday, April 4, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Fogarty
International Center Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the Discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
Date: May 25–26, 2011.
Closed: May 25, 2011, 2 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing, Room
B2C07, Bethesda, MD 20892.
Open: May 26, 2011, 9 a.m. to 3 p.m.
Agenda: Discussion topics to include
communications, policy research and publicprivate partnerships.
Place: National Institutes of Health,
Lawton Chiles International House, Bethesda,
MD 20892.
Contact Person: Robert Eiss, Public Health
Advisor, Fogarty International Center,
National Institutes of Health, 31 Center Drive,
Room B2c02, Bethesda, MD 20892, (301)
496–1415, EISSR@MAIL.NIH.GOV.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
VerDate Mar<15>2010
18:47 Apr 01, 2011
Jkt 223001
Information is also available on the
Institute’s/Center’s home page: https://
www.nih.gov/fic/about/advisory.html, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: March 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–7918 Filed 4–1–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Strategic Prevention
Framework State Incentive Grant (SPF
SIG) Program (OMB No. 0930–0279)
—Revision
SAMHSA’s Center for Substance
Abuse Prevention (CSAP) is responsible
for the evaluation instruments of the
Strategic Prevention Framework State
Incentive Grant (SPF SIG) Program. The
program is a major initiative designed
to: (1) Prevent the onset and reduce the
progression of substance abuse,
including childhood and underage
drinking; (2) reduce substance abuse
related problems; and (3) build
prevention capacity and infrastructure
at the State-, territorial-, Tribal- and
community-levels.
Five steps comprise the SPF:
Step 1: Profile population needs,
resources, and readiness to address the
problems and gaps in service delivery.
Step 2: Mobilize and/or build capacity
to address needs.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
18567
Step 3: Develop a comprehensive
strategic plan.
Step 4: Implement evidence-based
prevention programs, policies, and
practices and infrastructure
development activities.
Step 5: Monitor process, evaluate
effectiveness, sustain effective
programs/activities, and improve or
replace those that fail.
An evaluation team is currently
implementing a multi-method, quasiexperimental evaluation of the first two
Strategic Prevention Framework State
Incentive Grant (SPF SIG) cohorts
receiving grants in FY 2004 and FY
2005. A second evaluation is being
conducted with the SPF SIG Cohorts III,
IV and V. This notice invites comments
for revision to the protocol for the
ongoing cross-site evaluations of the
Strategic Prevention Framework State
Incentive Grant (SPF SIG) (OMB No.
0930–0279) which expires on 11/30/12.
This revision includes three parts:
(1) Continuation of the use of the
previously approved two-part
Community Level Instrument (CLI Parts
I and II) for Cohorts I and II and the use
of an instrument to assess the
sustainability of grantee implementation
and infrastructure accomplishments
which is a modification of an
instrument used in an earlier phase of
the evaluation.
(2) The addition of one more Cohort
(Cohort V) which will use the
previously approved SPF SIG cross-site
evaluation instruments. All three
instruments are modified versions of
data collection protocols used by
Cohorts I and II and have received OMB
approval (OMB No. 0930–0279). The
three instruments are:
a. A Grantee-Level SPF
Implementation Instrument,
b. A Grantee-Level Infrastructure
Instrument, and
c. A two-part Community-Level SPF
Implementation Instrument.
(3) Recalculation of burden numbers
for Cohort IV to replace estimates that
had been based on 20 grantees to reflect
the 25 grantees actually funded.
An additional Cohort III, IV, and V
evaluation component (i.e., participantlevel NOMs outcomes) is also included
in this submission as part of the
comprehensive evaluation, however, no
associated burden from this evaluation
activity is being imposed and therefore
clearance to conduct the activities is not
being requested. Specifically, Cohort III,
IV, and V SPF SIG grantees have been
included in the currently OMB
approved umbrella NOMs application
(OMB No. 0930–0230) covering the
collection of participant-level NOMs
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 76, Number 64 (Monday, April 4, 2011)]
[Notices]
[Page 18567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7918]
[[Page 18567]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Fogarty International Center Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the Discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: May 25-26, 2011.
Closed: May 25, 2011, 2 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Room B2C07, Bethesda, MD 20892.
Open: May 26, 2011, 9 a.m. to 3 p.m.
Agenda: Discussion topics to include communications, policy
research and public-private partnerships.
Place: National Institutes of Health, Lawton Chiles
International House, Bethesda, MD 20892.
Contact Person: Robert Eiss, Public Health Advisor, Fogarty
International Center, National Institutes of Health, 31 Center
Drive, Room B2c02, Bethesda, MD 20892, (301) 496-1415,
EISSR@MAIL.NIH.GOV.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nih.gov/fic/about/advisory.html, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: March 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-7918 Filed 4-1-11; 8:45 am]
BILLING CODE 4140-01-P